Clinical Trial Update: Contribution of F-18 Fluoro-Deoxy-Glucose PET/CT (Positron Emission Tomography) to the Assessment of HCC (Hepato-cellular Carcinoma) Treatment Efficiency

View source ↗

Summary

This clinical trial update examines how F-18 fluorodeoxyglucose positron emission tomography/computed tomography can contribute to assessing treatment response …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN